Utang agregat perusahaan: atricure.com (ATRC)

AtriCure, Inc. (ATRC) is developing methods to combat atrial fibrillation by creating equipment in collaboration with global cardiac surgeons and clinics. Effective management ensures FDA data transparency and high profitability through physician training. The business is currently scaling cryoablation systems and global approval programs. The individual debt metric stands at 0.08. This price action chart below demonstrates the market performance of this medtech manufacturer.

This indicator reflects the issuer's total liabilities, determining its financial stability and credit risk. Analyzing the total debt size allows for an assessment of the debt load relative to capitalization. The metric aggregates short-term and long-term borrowings, measuring the actual volume of external financing. For AtriCure, Inc. (ATRC), controlled leverage coupled with inelastic demand for cardiac surgery minimizes default risks. A stable cash flow from vital operations ensures the confident servicing of these obligations.